New drug under Real-World watch for duchenne patients
Disease control
Recruiting now
This study follows about 300 people with Duchenne muscular dystrophy who are taking the drug givinostat as part of their normal care. Researchers will track safety issues like low platelet counts and bleeding, and see how patients' muscle function changes over up to 5 years. The …
Sponsor: ITF Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC